Race Oncology Ltd Asset Resilience Ratio

Latest as of June 2024: 78.11%

Race Oncology Ltd asset resilience ratio. Race Oncology Ltd (RAC) has an Asset Resilience Ratio of 78.11% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Race Oncology Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$15.80 Million

≈ $11.18 Million USD Cash + Short-term Investments

Total Assets

AU$20.23 Million

≈ $14.31 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Race Oncology Ltd (2011–2024)

Asset resilience ratio of Race Oncology Ltd from 2011 to 2024. This chart shows how Race Oncology Ltd's Asset Resilience Ratio has changed over time. Read RAC liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Race Oncology Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Race Oncology Ltd asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$15.80 Million	78.11%
Total Liquid Assets	AU$15.80 Million	78.11%

Asset Resilience Insights

Very High Liquidity: Race Oncology Ltd maintains exceptional liquid asset reserves at 78.11% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Race Oncology Ltd Industry Peers by Asset Resilience Ratio

Compare Race Oncology Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Race Oncology Ltd Asset Resilience Ratio by Year (2011–2024)

Race Oncology Ltd asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Race Oncology Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	78.11%	AU$15.80 Million ≈ $11.18 Million	AU$20.23 Million ≈ $14.31 Million	+4.53pp
2023-06-30	73.58%	AU$19.60 Million ≈ $13.87 Million	AU$26.64 Million ≈ $18.85 Million	+0.29pp
2022-06-30	73.28%	AU$27.50 Million ≈ $19.46 Million	AU$37.52 Million ≈ $26.55 Million	--
2017-06-30	0.00%	AU$0.00 ≈ $0.00	AU$6.00 Million ≈ $4.25 Million	--
2013-12-31	3.45%	AU$9.99 Million ≈ $7.07 Million	AU$289.97 Million ≈ $205.18 Million	+0.67pp
2012-12-31	2.77%	AU$10.00 Million ≈ $7.08 Million	AU$360.83 Million ≈ $255.31 Million	-11.31pp
2012-06-30	14.09%	AU$60.00 Million ≈ $42.45 Million	AU$425.96 Million ≈ $301.39 Million	+5.95pp
2011-06-30	8.13%	AU$30.92 Million ≈ $21.88 Million	AU$380.25 Million ≈ $269.05 Million	--

pp = percentage points

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$204.63 Million

AU$289.20 Million AUD

Market Cap Rank

#16218 Global

#445 in Australia

Share Price

AU$1.48

Change (1 day)

-0.34%

52-Week Range

AU$1.40 - AU$3.46

All Time High

AU$4.70